Atropine slows axial elongation over two years in MAD trial

A 2-year interim analysis of the Myopia Atropine Dose (MAD) randomized clinical trial found modest axial elongation in children treated with atropine. The findings were presented in a poster at the ARVO 2026 Annual Meeting. The ongoing double-masked, multicenter trial includes Dutch children aged 6–11 years with progressive myopia and...